Loading...

Héžová Renata

Mgr. Renata Héžová, Ph.D.

researcher

Research activities

PREPARATION AND PURIFICATION OF RECOMBINANT PROTEINS FOR IMMUNIZATION AND DIAGNOSTIC PURPOSES

IMMUNE RESPONSE ASSESSMENT, GENE EXPRESSION

CANCER BIOLOGY

Project involvement


FIT (Pharmacology, Immunotherapy, nanoToxicology)

OP RDE project of the Ministry of Education, Youth and Sports of the Czech Republic – Reg.No. CZ.02.1.01/0.0/0.0/15_003/0000495

Education

2013

Ph.D. – Faculty of Medicine and Dentistry, Palacký University, Olomouc

Selected publications

Oncolysate-loaded Escherichia coli bacterial ghosts enhance the stimulatory capacity of human dendritic cells

Michalek J, Hezova R, Turanek-Knötigova P, Gabkova J, Strioga M, Lubitz W, Kudela P., 2017. Cancer Immunol Immunother Volume: 66(2), 149-159.

miR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus

Hezova R, Kovarikova A, Srovnal J, Zemanova M, Harustiak T, Ehrmann J, Hajduch M, Sachlova M, Svoboda M, Slaby O., 2016. Tumour Biol 37(6), 8007-18

miR-155 and miR-484 are associated with time to progression in metastatic renal cell carcinoma treated with sunitinib

Merhautova J, Hezova R, Poprach A, Kovarikova A, Radova L, Svoboda M, Vyzula R, Demlova R, Slaby O., 2015. Biomed Res Int. 941980

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus

Hezova R, Kovarikova A, Srovnal J, Zemanova M, Harustiak T, Ehrmann J, Hajduch M, Svoboda M, Sachlova M, Slaby O., 2015. Diagn Pathol. 28;10:42.

MicroRNA profiling of activated and tolerogenic human dendritic cells

Stumpfova Z, Hezova R, Meli AC, Slaby O, Michalek J., 2014. Mediators Inflamm. 259689

Microrna-342, microrna-191 and microrna-510 are differentially expressed in t regulatory cells of type 1 diabetic patients

Hezova R, Slaby O, Faltejskova P, Mikulkova Z, Buresova I, Raja KR, Hodek J, Ovesna J, Michalek J., 2009. Cell Immunol. 260:70-74